Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

Rockland Trust will be moving its corporate headquarters back to Rockland, the South Shore town where it was first formed.

After developing treatments for rare tumors, SpringWorks Therapeutics is taking a buyout offer from Germany-based Merck KGaA.

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

The deal, which has been in the works for months, hands the German pharmaceutical company two approved drugs for rare tumors.